Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fink

Showing results (291-300 of 363) with videos related to

Pageof 37
Sort By:
Comparative Medicine|December 16, 2023
Antibiotic Treatment of <i>Corynebacterium bovis</i>-associated Clinical Disease in NSG MiceElena M Pires, Umarani Pugazhenthi, Michael K Fink, et al.
Annals of the American Thoracic Society|April 15, 2016
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease RegistryEmily A Knapp, Aliza K Fink, Christopher H Goss, et al.
Gastroenterology|December 31, 2017
Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal CancerAndrea Gini, Ann G Zauber, Dayna R Cenin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 2, 2019
Predictors of pulmonary exacerbation treatment in cystic fibrosisDon B Sanders, Joshua S Ostrenga, Margaret Rosenfeld, et al.
Comparative Medicine|February 6, 2023
A Clinical Scoring Systems for the Evaluation of <i>Corynebacterium bovis</i> -associated Disease in NSG MiceChristopher A Manuel, Emily C Pearson, Umarani Pugazhenthi, et al.
Gastroenterology|November 6, 2017
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal CancerAndrea Gini, Ann G Zauber, Dayna R Cenin, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 31, 2019
Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene DeliveryJason T Rodier, Ratnakar Tripathi, Michael K Fink, et al.
Neuropharmacology|August 7, 2013
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotineS Charntikov, N Swalve, S Pittenger, et al.
Particle and Fibre Toxicology|June 20, 2019
ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposureAmina Kunovac, Quincy A Hathaway, Mark V Pinti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 26, 1997
Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptorsE Schlicker, K Fink, G J Molderings, et al.
Pageof 37

Showing results (291-300 of 363) with videos related to

Sort By:
Pageof 37
Comparative Medicine|December 16, 2023
Antibiotic Treatment of <i>Corynebacterium bovis</i>-associated Clinical Disease in NSG MiceElena M Pires, Umarani Pugazhenthi, Michael K Fink, et al.
Annals of the American Thoracic Society|April 15, 2016
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease RegistryEmily A Knapp, Aliza K Fink, Christopher H Goss, et al.
Gastroenterology|December 31, 2017
Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal CancerAndrea Gini, Ann G Zauber, Dayna R Cenin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 2, 2019
Predictors of pulmonary exacerbation treatment in cystic fibrosisDon B Sanders, Joshua S Ostrenga, Margaret Rosenfeld, et al.
Comparative Medicine|February 6, 2023
A Clinical Scoring Systems for the Evaluation of <i>Corynebacterium bovis</i> -associated Disease in NSG MiceChristopher A Manuel, Emily C Pearson, Umarani Pugazhenthi, et al.
Gastroenterology|November 6, 2017
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal CancerAndrea Gini, Ann G Zauber, Dayna R Cenin, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 31, 2019
Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene DeliveryJason T Rodier, Ratnakar Tripathi, Michael K Fink, et al.
Neuropharmacology|August 7, 2013
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotineS Charntikov, N Swalve, S Pittenger, et al.
Particle and Fibre Toxicology|June 20, 2019
ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposureAmina Kunovac, Quincy A Hathaway, Mark V Pinti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 26, 1997
Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptorsE Schlicker, K Fink, G J Molderings, et al.
Pageof 37